Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 217-614-1 | CAS number: 1908-87-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity: LD50 = 1218 mg/kg bw (males) and 1203 mg/kg bw (females) for rats (similar to OECD 401)
Acute dermal toxicity: LD50 > 500 mg/kg, no effects at this dose were seen in rats (similar to OECD 402)
Acute inhalation toxicity: LC0 ≥ 600 mg/m³ air (rats, dust), LC0 ≥ 24725 mg/m³ air (mice, rats, vapour), LC0 ≥ 24650 mg/m³ air (hamsters, rabbits, vapour) (similar to OECD 403, 4h exposure)
Acute intraperitoneal toxicity: LD50 = 291 mg/kg bw (males) and 253 mg/kg bw (females) (rats, ip injection)
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study conducted prior to GLP similar to OECD guideline 401 on the registered substance itself. The method is to be considered scientifically reasonable with minor deficiencies in documentation.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- not applicable
- GLP compliance:
- no
- Remarks:
- test conducted prior to GLP implementation
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- other: Wistar-II
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Winkelmann animal breeder (Kirchborchen, Paderborn district) and Gierlich animal breeder (Bochum)
- Weight at study initiation: 160-210g
- Housing: macrolon cages, Type III
- Diet (e.g. ad libitum): Altromin R Standard diets (Altromin GmbH, Lage/Lippe) ad libitum
- Water (e.g. ad libitum): ad libitum - Route of administration:
- oral: gavage
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 1, 2, 5, 10 , 20, 24, 30, 40%
- Amount of vehicle (if gavage): 0.5ml / 100 g bw - Doses:
- 50, 100, 250, 500, 1000, 1200, 1500, 2000 mg/kg (males; females only 50-1500 mg/kg)
- No. of animals per sex per dose:
- 15
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs - Statistics:
- The determination of the average lethal dose (LD50) was made using a Probit analysis (FINK und HUND, Arzneimittelforschung 15, 624, 1965).
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 218 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 1 098 - 1 337
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 203 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 1 086 - 1 331
- Mortality:
- See 'Any other information on results incl. tables'
- Clinical signs:
- other: Appearance of poisoning: Symptoms of poisoning in the form of reduced general well-being, difficult breathing, reduced reflexes and lying on the stomach began 2 minutes to 24 hours after the application with the rats. The difficult breathing lasted up to
- Gross pathology:
- The livers of the dead animals exhibited a spotty appearance when sectioned.
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The study was conducted prior to GLP similar to OECD guideline 401 on the registered substance itself. The method is to be considered scientifically reasonable with minor deficiencies in documentation. Hence, the results can be considered as sufficiently reliable to assess the acute oral toxicity in rats. The determined LD50 values are 1218 mg/kg bw (males) resp. 1203 mg/kg bw (females). The results for both sexes are hence consistant and suitable to determine the classification of N-Methyl-2-thion-thiazolidine. According to Regulation (EC) No. 1272/2008, the substance needs to be classified as acute toxic cat. IV.
- Executive summary:
In an acute oral toxicity study similar to OECD guideline 401, groups of Wistar-II rats (15/sex/dose) were given a single oral dose N-Methyl-2-thion-thiazolidine in polyethylene glycol 400 at doses of 50, 100, 250, 500, 1000, 1200, 1500, 2000 mg/kg (males; females only 50-1500 mg/kg) and observed for 14 days. The following oral LD50 were determined:
Males = 1218 mg/kg bw (95% C.I. 1098 - 1337)
Females = 1203 mg/kg bw (95% C.I. 1086 - 1331)
Symptoms of poisoning were a significant reduction of the general well-being, difficult breathing and reduction of the reflexes. Mortality occurred after 8 minutes to 6 days.
N-Methyl-2-thion-thiazolidine is of slight toxicity based on the LD50 in females, leading to the classification as acute toxic Cat. IV according to Regulation (EC) No. 1272/2008.
Reference
Table 1: Results
Dose / mg/kg |
Conc. in vehicle / % |
Toxicol. Results after 14 d* |
Symptoms of poisoning |
Occurence of Death after |
|
Start |
End |
||||
Male Rats |
|||||
50 |
1 |
0/0/15 |
- |
- |
- |
100 |
2 |
0/15/15 |
24 h |
2 d |
- |
250 |
5 |
0/15/15 |
24 h |
4 d |
- |
500 |
10 |
0/15/15 |
1 h |
9 d |
- |
1000 |
20 |
3/15/15 |
16 min |
9 d |
1 – 6 d |
1200 |
24 |
7/15/15 |
10 min |
10 d |
1 – 2 d |
1500 |
30 |
12/15/15 |
4 min |
12 d |
1 – 2 d |
2000 |
40 |
15/15/15 |
2 min |
- |
1 – 2 d |
Female Rats |
|||||
50 |
1 |
0/0/15 |
- |
- |
- |
100 |
2 |
0/15/15 |
24 h |
2 d |
- |
250 |
5 |
0/15/15 |
24 h |
3 d |
- |
500 |
10 |
0/15/15 |
1.5 h |
9 d |
- |
1000 |
20 |
3/15/15 |
20 min |
7 d |
1 – 2 d |
1200 |
24 |
7/15/15 |
15 min |
7 d |
1 – 2 d |
1500 |
30 |
13/15/15 |
15 min |
9 d |
1 – 2 d |
*1stNumber = Number of dead animals
2ndNumber = Number of animals with symptoms
3rdNumber = Number of animals used
Highest dose without finding (m/f): 50 mg/kg
Lowest lethal dose (m/f): 1000 mg/kg
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 203 mg/kg bw
- Quality of whole database:
- The available data meets fully the tonnage-driven data requirements of REACH. The study and its results are sufficiently reliable due to the applied method, documentation and plausibility compared to the results of the tests of the other application routes. Hence, the database is of good quality.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study conducted prior to GLP similar to OECD guideline 403 on the registered substance itself. The method is to be considered scientifically reasonable with minor deficiencies in documentation.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- not applicable
- GLP compliance:
- no
- Remarks:
- test conducted prior to GLP implementation
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- other: mice, rats, hamsters, rabbits
- Strain:
- other: NMRI mice, Wistar-II rats, Syrian gold hamsters and albino rabbits
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Winkelmann animal breeder (Kirchborchen, Paderborn district) and Gierlich animal breeder (Bochum)
- Weight at study initiation: 160-210g (rats), 25-31g (mice), 60-75g (hamsters), 3.5-4.3kg (rabbits)
- Housing: macrolon cages, Type III (rats, mice, hamsters), individually in standard rabbit cages (Manufacturer: E. Pluppins, Hamburg) (rabbits)
- Diet (e.g. ad libitum): Altromin R Standard diets (Altromin GmbH, Lage/Lippe) (mice, rats), sniff full diet feed for hamsters (Intermast GmbH, Bockum-Hövel) (hamsters), Höing rabbit feed (rabbits) ad libitum
- Water (e.g. ad libitum): ad libitum - Route of administration:
- other: dust or vapour
- Type of inhalation exposure:
- other: only through breathing (dust), whole body (vapour)
- Vehicle:
- not specified
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: dusting device (from JÖTTEN) (dust) / electrical heating pot (vapour)
- Exposure chamber volume: 20L cylinder (dust) / 0.4m³ chamber (vapour)
TEST ATMOSPHERE
- Brief description of analytical method used: analysis of the weight (dust) / gas chromatograph with the help of a nitrogen detector (vapour) - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- analysis of weight or gas chromatography
- Duration of exposure:
- 4 h
- Concentrations:
- 600 mg/m³ (dust); 137, 207, 24,725, 24,650 mg/m³ (vapour), see results for details
- No. of animals per sex per dose:
- 10 rats/sex (dust)
in total 20 mice, 10 rats, 5 hamsters and 2 rabbits per dose, sex not stated (vapour) - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Other examinations performed: clinical signs - Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 600 mg/m³ air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other: dust, rats
- Sex:
- male/female
- Dose descriptor:
- LC0
- Effect level:
- >= 600 mg/m³ air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other: dust, rats
- Sex:
- not specified
- Dose descriptor:
- LC0
- Effect level:
- >= 24 725 mg/m³ air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other: vapour, mice and rats, concentration calculated mathematically
- Sex:
- not specified
- Dose descriptor:
- LC0
- Effect level:
- >= 24 650 mg/m³ air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other: vapour, hamsters and rabbits, concentration calculated mathematically
- Mortality:
- no mortality occurred
- Clinical signs:
- other: Neither death nor symptoms of poisoning occurred immediately after the 4-hour exposure or in the following 14-day post-observation time with the rats. The vapours formed with the heating of the test item at 100°C and 200°C caused no appearance of poisonin
- Interpretation of results:
- other: EU-GHS criteria not met
- Conclusions:
- The study was conducted prior to GLP similar to OECD guideline 402 on the registered substance itself. The method is to be considered scientifically reasonable with minor deficiencies in documentation. Hence, the results can be considered as sufficiently reliable to assess the acute oral toxicity in rats. The LC0 for dust was determined as ≥ 600 mg/m³ air in rats, and the LC0 for vapour was determined as ≥ 24725 mg/m³ air (rats, mice) and ≥24650 mg/m³ air (hamsters, rabbits), respectively. The results for both sexes and all species are consistent and suitable to determine the classification of N-Methyl-2-thion-thiazolidine. According to Regulation (EC) No. 1272/2008, the substance does not need to be classified as acute toxic by inhalation.
- Executive summary:
In an acute inhalation toxicity study (similar to OECD 403), groups of Wistar-II rats (10/sex) were exposed by inhalation route to dusts of N-Methyl-2-thion-thiazolidine for 4 hours (inhalation only) at a concentration of 600 mg/m³. Further, Wistar-II rats (20/group), NMRI mice (10/group), Syrian gold hamsters (5/group) and albino rabbits (2/group) were exposed by inhalation route to vapours of N-Methyl-2-thion-thiazolidine for 4 hours (whole body) at concentrations of 137 and 24,725 mg/m³ (rats, mice) and 207 and 24,650 mg/m³. Animals then were observed for 14 days.
LC50 > 600 mg/m³ (dust, rats, m/f)
LC0 ≥ 600 mg/m³ (dust, rats, m/f)
LC0 ≥ 24,725 mg/m³ (vapour, rats, mice)
LC0 ≥ 24,650 mg/m³ (vapour, hamsters, rabbits)
With the dynamic dusting of N-Methyl-2-thion-thiazolidine, an LC50 >600mg/m³ air resulted with a one-time four-hour exposure for male and female rats. With this concentration, no symptoms of poisoning appeared immediately after the exposure or in the following 14-day post-observation time.
When N-Methyl-2-thion-thiazolidine was vaporised (at 100 or 200°C), there were no injuries in the case of rats, mice, rabbits and hamsters through a four-hour exposure.
N-Methyl-2-thion-thiazolidine is classified as being of low toxicity based on the results above and does not trigger classification as acute toxic by inhalation.
Reference
Table 1: Results of the acute toxicity study with vapour
Test item / g |
Concentration of test item / mg/m³ air Calculated mathematically |
Vaporising temperature / °C |
Test duration / h |
Animals |
Toxicol. Results after 14d* |
|
Inserted |
Vaporised |
|||||
4.0 |
0.055 |
137 |
100 |
4 |
Mice |
0/0/20 |
Rats |
0/0/10 |
|||||
4.0 |
0.083 |
207 |
100 |
4 |
Hamsters |
0/0/5 |
Rabbits |
0/0/2 |
|||||
10.0 |
9.892 |
24725 |
200 |
4 |
Mice |
0/0/20 |
Rats |
0/0/10 |
|||||
10.0 |
9.863 |
24650 |
200 |
4 |
Hamsters |
0/0/5 |
Rabbits |
0/0/2 |
*1stNumber = Number of dead animals
2ndNumber = Number of animals with symptoms
3rdNumber = Number of animals used
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- The available data meets fully the tonnage-driven data requirements of REACH. The study and its results are sufficiently reliable due to the applied method, documentation and plausibility compared to the results of the tests of the other application routes. Hence, the database is of good quality.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study conducted prior to GLP similar to OECD guideline 402 on the registered substance itself. The method is to be considered scientifically reasonable with minor deficiencies in documentation, and only one dose (no limit dose) was tested.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- not applicable
- GLP compliance:
- no
- Remarks:
- test conducted prior to GLP implementation
- Test type:
- other: single dose application
- Limit test:
- no
- Species:
- rat
- Strain:
- other: Wistar-II
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Winkelmann animal breeder (Kirchborchen, Paderborn district) and Gierlich animal breeder (Bochum)
- Weight at study initiation: 160-210g
- Housing: macrolon cages, Type III
- Diet (e.g. ad libitum): Altromin R Standard diets (Altromin GmbH, Lage/Lippe) ad libitum
- Water (e.g. ad libitum): ad libitum - Type of coverage:
- occlusive
- Vehicle:
- polyethylene glycol
- Remarks:
- 400
- Details on dermal exposure:
- TEST SITE
- Area of exposure: skin of the backs
- Type of wrap if used: aluminium foil and wide ahhesive plaster strip
REMOVAL OF TEST SUBSTANCE
- Washing (if done): yes
- Time after start of exposure: 24h
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 500 mg/kg bw
- Concentration (if solution): 25% emulsion - Duration of exposure:
- 24 h
- Doses:
- 500 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Other examinations performed: clinical signs - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 500 mg/kg bw
- Based on:
- test mat.
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- >= 500 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No cases of death occurred.
- Clinical signs:
- other: No symptoms of poisoning appeared with the rats in the first 24 hours after the application or during the 14-day post-observation time.
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- The study was conducted prior to GLP similar to OECD guideline 402 on the registered substance itself. The method is to be considered scientifically reasonable with minor deficiencies in documentation, and only one dose (no limit dose) was tested. Hence, the results can be considered at least as sufficiently reliable to assess the dermal oral toxicity in rats. Since the test item was only tested at a dose of 500 mg/kg, which does not correspond to the limit dose, and no effects were seen, there can no absolute conclusions be made regarding the substances definitive classification under the CLP Regulation. It can only be stated that the substance is relatively harmless as does not trigger classification as acute toxic Cat. III or higher.
- Executive summary:
In an acute dermal toxicity study similar to OECD 402, two groups of each five male and female rats were dermally exposed to the test item in polyethylene glycol 400 for 24 hours to the skin on the backs at a dose of 500 mg/kg bw. Animals then were observed for 14 days.
No cases of death occurred and no symptoms of poisoning appeared with the rats in the first 24 hours after the application or during the 14-day post-observation time. A dermal LD50 >500 mg/kg therefore results for both sexes.
The test item is hence of low Toxicity.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- The available data meets fully the tonnage-driven data requirements of REACH. The study and its results are sufficiently reliable due to the applied method, documentation and plausibility compared to the results of the tests of the other application routes. Hence, the database is of good quality.
Additional information
There are four acute toxicity studies available on 3-methylthiazolidine-2-thione, which are mostly conducted similar to the recent respective OECD guidelines, conducted prior to GLP implementation:
Acute oral toxicity: The following oral LD50 were determined:
Males = 1218 mg/kg bw (95% C.I. 1098 - 1337)
Females = 1203 mg/kg bw (95% C.I. 1086 - 1331)
Symptoms of poisoning were a significant reduction of the general well-being, difficult breathing and reduction of the reflexes. Mortality occurred after 8 minutes to 6 days.
N-Methyl-2-thion-thiazolidine is of slight toxicity based on the LD50 in females, leading to the classification as acute toxic Cat. IV according to Regulation (EC) No. 1272/2008.
Acute dermal toxicity: No cases of death occurred and no symptoms of poisoning appeared with the rats in the first 24 hours after the application or during the 14-day post-observation time. A dermal LD50 >500 mg/kg therefore results for both sexes.
The test item is hence of low Toxicity.
Acute inhalation toxicity: The following inhalative LC50/LC0 were determined:
LC50 > 600 mg/m³ (dust, rats, m/f)
LC0 ≥ 600 mg/m³ (dust, rats, m/f)
LC0 ≥ 24,725 mg/m³ (vapour, rats, mice)
LC0 ≥ 24,650 mg/m³ (vapour, hamsters, rabbits)
With the dynamic dusting of N-Methyl-2-thion-thiazolidine, an LC50 >600mg/m³ air resulted with a one-time four-hour exposure for male and female rats. With this concentration, no symptoms of poisoning appeared immediately after the exposure or in the following 14-day post-observation time.
When N-Methyl-2-thion-thiazolidine was vaporised (at 100 or 200°C), there were no injuries in the case of rats, mice, rabbits and hamsters through a four-hour exposure.
N-Methyl-2-thion-thiazolidine is classified as being of low toxicity based on the results above and does not trigger classification as acute toxic by inhalation.
Acute intraperitoneal toxicity: The following ip LD50 were determined:
Males = 291 mg/kg bw (95% C.I. 266 - 318)
Females = 253 mg/kg bw (95% C.I. 233 - 274)
Symptoms of poisoning were a reduction of the general well-being, difficult breathing and cramps. Death occurred within 24 hours after the application.
All
required routes of application are covered, no data gaps were
identified, as all data is considered sufficiently reliable. The
relative magnitude of the results derived from the different routes of
application are in the expected range when taking into account the
sensitivity of the routes and the possible differences in absorption,
making the results plausible and sufficient for human risk assessment.
3-methylthiazolidine-2-thione is to be considered slightly toxic.
Justification for classification or non-classification
Both the inhalation and dermal study did not reveal any signs of toxicity. The only available LD50 values are via the oral and intraperitoneal route. The ip route is not relevant for classification according to Regulation (EC) No. 1272/2008, leaving only the oral LD50 in female rats (more sensitive sex) to assess the need for classification. The oral LD50 of 1203 mg/kg bw lies between the boundary values of 300 and 2000 mg/kg bw, triggering the classification of 3-methylthiazolidine-2-thione as acute toxic Cat. IV according to Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.